In-vitro Toxicology Testing Market
In-vitro Toxicology Testing Market Scope: Industry
Analysis, Market Size, Growth, Trends Till 2031
Request Sample Report
In-vitro Toxicology Testing Market Size and Growth
The In-vitro Toxicology Testing market is experiencing robust growth, valued at approximately $3.2 billion in 2023. Rising regulatory demands and advancements in technology are driving market expansion. Key sectors include pharmaceuticals, cosmetics, and chemicals, with North America leading in market share, propelled by increased research and development activities.
Sample Report
Companies Covered
(Covid 19 Impact Covered)
◍ Abbott
◍ Covance
◍ GE Healthcare
◍ Quest Diagnostics Inc.
◍ Thermo Fisher Scientific Inc.
◍ Bio-Rad Laboratories
◍ Catalent Pharma Solutions
◍ Cyprotex
◍ Agilent Technologies
◍ Charles River Laboratories
◍ Merck KgaA
◍ Eurofins Scientific Inc.
The in-vitro toxicology testing market is expanding due to rising drug development costs and regulatory pressures. Companies like Thermo Fisher Scientific and Charles River Laboratories enhance market growth through innovative testing solutions. Sales revenue figures include:
- Thermo Fisher: $40 billion
- Merck KGaA: $24 billion
- Covance: $1 billion (part of LabCorp).
Request Sample Report
